BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 28408729)

  • 1. RETRACTION.
    Kurume Med J; 2016; 63(1.2):49. PubMed ID: 28408729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retraction Note: Three-year Experience with Alendronate Treatment in Postmenopausal Osteoporotic Japanese Women with or without Renal Dysfunction: A Retrospective Study.
    Iwamoto J; Sato Y; Uzawa M; Takeda T; Matsumoto H
    Drugs Aging; 2019 Oct; 36(10):979. PubMed ID: 31418156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retraction: 'Sunlight exposure is important for preventing hip fractures in patients with Alzheimer's disease, Parkinson's disease, or stroke' by J. Iwamoto, T. Takeda and H. Matsumoto.
    Acta Neurol Scand; 2018 Jun; 137(6):630. PubMed ID: 29732540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retracted: Effects of Vitamin K2 on Osteoporosis.
    Iwamoto J; Takeda T; Sato Y
    Curr Pharm Des; 2004; 10(21):2557-76. PubMed ID: 15320745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retracted Note: Effects of Vitamin K2 on Osteoporosis.
    Iwamoto J; Takeda T; Sato Y
    Curr Pharm Des; 2021; 27(19):2325. PubMed ID: 34264184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RETRACTED: Menatetrenone and vitamin D2 with calcium supplements prevent nonvertebral fracture in elderly women with Alzheimer's disease.
    Sato Y; Kanoko T; Satoh K; Iwamoto J
    Bone; 2005 Jan; 36(1):61-8. PubMed ID: 15664003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retraction: 'Alendronate and vitamin D2 for prevention of hip fracture in Parkinson's disease: A randomized controlled trial,' by Sato, Y., Iwamoto, J., Kanoko, T., and Satoh, K.
    Mov Disord; 2016 Jul; 31(7):1077. PubMed ID: 27374761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Notice of Retraction: Sato Y, et al. The Prevention of Hip Fracture With Risedronate and Ergocalciferol Plus Calcium Supplementation in Elderly Women With Alzheimer Disease: A Randomized Controlled Trial. Arch Intern Med. 2005;165(15):1737-1742.
    Bauchner H; Redberg RF
    JAMA Intern Med; 2016 Sep; 176(9):1256. PubMed ID: 27258431
    [No Abstract]   [Full Text] [Related]  

  • 9. Article retraction. Sato Y, Honda Y, Iwamoto J, Amano N. Comparison of non-vertebral fracture between minodronate and risedronate therapy in elderly female patients with Alzheimer disease. J Musculoskelet Neuronal Interact 2013;13:346-52.
    J Musculoskelet Neuronal Interact; 2016 Sep; 16(3):264. PubMed ID: 27609042
    [No Abstract]   [Full Text] [Related]  

  • 10. Articles retraction.
    J Musculoskelet Neuronal Interact; 2018 Jun; 18(2):280. PubMed ID: 29855452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Takeda K, Cretney E, Hayakawa Y, Ota T, Akiba H, Ogasawara K, Yagita H, Kinoshita K, Okumura K, Smyth MJ. TRAIL identifies immature natural killer cells in newborn mice and adult mouse liver. Blood. 2005;105(5):2082-2089.
    Blood; 2023 Nov; 142(21):1848. PubMed ID: 37793089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retracted publications in the drug literature.
    Samp JC; Schumock GT; Pickard AS
    Pharmacotherapy; 2012 Jul; 32(7):586-95. PubMed ID: 22581659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retraction: 'Abnormal bone and calcium metabolism in immobilized Parkinson's disease patients,' by Sato Y., Honda Y., Iwamoto, J., Kanoko, T., and Satoh, K.
    Mov Disord; 2019 Jan; 34(1):156. PubMed ID: 30653727
    [No Abstract]   [Full Text] [Related]  

  • 14. The continued use of retracted, invalid scientific literature.
    Pfeifer MP; Snodgrass GL
    JAMA; 1990 Mar; 263(10):1420-3. PubMed ID: 2406475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retraction: 'Beneficial Effect of Intermittent Cyclical Etidronate Therapy in Hemiplegic Patients Following an Acute Stroke' by Y. Sato, T. Asoh, M. Kaji and K. Oizumi.
    J Bone Miner Res; 2016 Oct; 31(10):1911. PubMed ID: 27759930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Editor Response: Retraction: Risedronate Therapy For Prevention Of Hip Fracture After Stroke In Elderly Women; Risedronate Therapy For Prevention Of Hip Fracture After Stroke In Elderly Women: Reply From The Authors.
    Gross RA; Griggs RC
    Neurology; 2017 Jan; 88(2):221. PubMed ID: 28069980
    [No Abstract]   [Full Text] [Related]  

  • 17. Letter Re: Retraction: Risedronate Therapy For Prevention Of Hip Fracture After Stroke In Elderly Women; Risedronate Therapy For Prevention Of Hip Fracture After Stroke In Elderly Women: Reply From The Authors.
    Kappos L
    Neurology; 2017 Jan; 88(2):221. PubMed ID: 28069979
    [No Abstract]   [Full Text] [Related]  

  • 18. Publication misconduct and plagiarism retractions: a systematic, retrospective study.
    Stretton S; Bramich NJ; Keys JR; Monk JA; Ely JA; Haley C; Woolley MJ; Woolley KL
    Curr Med Res Opin; 2012 Oct; 28(10):1575-83. PubMed ID: 22978774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retractions by Pakistan Journal of Medical Sciences due to Scientific Misconduct.
    Jawaid SA; Jawaid M
    J Coll Physicians Surg Pak; 2016 Aug; 26(8):718-9. PubMed ID: 27539774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of bone loss and vertebral fractures in patients with chronic epilepsy--antiepileptic drug and osteoporosis prevention trial.
    Lazzari AA; Dussault PM; Thakore-James M; Gagnon D; Baker E; Davis SA; Houranieh AM
    Epilepsia; 2013 Nov; 54(11):1997-2004. PubMed ID: 24010637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.